Status:
COMPLETED
In-Use Test With a Cosmetic Product
Lead Sponsor:
Dr. August Wolff GmbH & Co. KG Arzneimittel
Collaborating Sponsors:
SIT Skin Investigation and Technology Hamburg GmbH
Conditions:
Dermatitis, Atopic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the tolerance of the product WO 4260 by a dermatologist. Additional objectives of this clinical in-use study are to evaluate the cosmetic features and acceptance of...
Eligibility Criteria
Inclusion
- age: ≥ 18 years
- sex: approx. 50% male and approx. 50% female
- users of hair tonic for dry scalp
- dry, itchy scalp prone to atopic eczema / atopic dermatitis
Exclusion
- any deviation from the above-mentioned criteria
- users of sour hair rinse
- subjects who wash their hair more than once a day
- other dermatological disorders (scars, moles) on the scalp
- known incompatibilities to cosmetics and ingredients of cosmetic test products (please see INCI)
- topical medication in the test area within 1 month prior to study start
- systemic medication with anti-inflammatory agents and antibiotics within 2 weeks prior to starting of the study
- systemic medication with retinoids, antihistamines and/or immunomodulators (e.g. cortisone, corticosterone, chemotherapeutic agents) within 4 weeks prior to starting of the study
- systemic illness of the subject at the beginning of the study
- pregnancy and period of breastfeeding
Key Trial Info
Start Date :
January 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2017
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03252730
Start Date
January 30 2017
End Date
February 27 2017
Last Update
August 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SIT Skin Investigation and Technology Hamburg GmbH
Hamburg, Germany, 20354